Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers Systematic review and meta-analysis finds CAR T-cell-specific toxicities only account for 11.5% Sep 04, 2024
BTK Inhibitor Active in Half of Patients With Richter Transformation Responses to pirtobrutinib observed in patients with previously treated disease Sep 03, 2024
Mixed Results With Cyclophosphamide in Mismatched Unrelated Stem Cell Transplants Better survival in one registry study, detriment with class I HLA mismatch in another Aug 27, 2024
Alarm Over Pharma-China Link; Taking Screening to the People; Agriculture and Cancer News, features, and commentary about cancer-related issues Aug 23, 2024
More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer News, features, and commentary about cancer-related issues Aug 16, 2024
IL-2 Receptor-Targeted Therapy Approved for Relapsed/Refractory CTCL New iteration of denileukin diftitox led to objective responses in 36% of pretreated patients Aug 08, 2024
Ancient DNA May Fuel Cancer; ASCO Appeals to Oncologists; Pesticide Cancer Risk News, features, and commentary about cancer-related issues Jul 26, 2024
'Realistic Chance for Pregnancy' After Stem Cell Transplant, German Study Suggests 77% of pregnancies resulted in live births Jul 19, 2024
A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Toll News, features, and commentary about cancer-related issues Jul 12, 2024
If CD19 CAR T-Cell Therapy Fails in Lymphoma, Try a CD22 Version Durable response possible with treatment targeting a different antigen Jul 10, 2024
Pivotal Studies in Double-Expressor DLBCL Yield Divergent Results R-CHOP plus venetoclax falls short, while R-CHOP with HDAC inhibitor shows promise Jul 02, 2024 video
Neuromuscular Training Decreased Incidence of Chemo-Induced Peripheral Neuropathy Incidence significantly reduced with two types of exercises versus usual care Jul 01, 2024
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials News, features, and commentary about cancer-related issues Jun 28, 2024
Combo of Approved Agents Active in High-Risk Large B-Cell Lymphoma Our panel of experts discusses mosunetuzumab/polatuzumab vedotin for relapsed/refractory patients Jun 25, 2024 video
EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancer News, features, and commentary about cancer-related issues Jun 21, 2024
Glofitamab Regimen Improves Survival in DLBCL Granted accelerated approval last year, bispecific antibody passes its confirmatory test Jun 20, 2024
Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL High-rate of durable responses with ViPOR sparks talk of supplanting CAR-T in second line Jun 19, 2024
Atezolizumab Consolidation Impresses in High-Risk DLBCL Will 2-year DFS of 88%, OS of 96% renew interest in checkpoint inhibitor consolidation? Jun 14, 2024
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break? News, features, and commentary about cancer-related issues Jun 13, 2024
New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy Co-mutations, viral link, potential common susceptibility emerge from two studies Jun 12, 2024
Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study Second-gen ALK inhibitor induces high response rate, associated with impressive survival Jun 12, 2024
Near-Perfect Control of Slow-Growing Lymphoma With Low-Dose Radiotherapy All but four of 24 patients had complete responses to 4 Gy, local control rate of 96% at 3 years Jun 06, 2024
Star Singer's Illness; AI Imitating the Dead; Internet-Addicted Brains Health news and commentary gathered by ΒιΆΉ΄«Γ½ staff Jun 05, 2024
Triplet Notches Survival Win in Heavily Pretreated DLBCL Benefit with BV plus lenalidomide-rituximab seen in those who relapsed after CAR-T or transplant Jun 02, 2024
Kinder, Gentler Regimen for Classical Hodgkin Prevails in Randomized Trial Better efficacy with brentuximab vedotin versus standard chemo, substantially less toxicity Jun 01, 2024
Fewer Suicides in Cancer Patients; Circadian Rhythm Boost; HIV Vaccine for Cancer? News, features, and commentary about cancer-related issues May 31, 2024
Tattoos May Be a Risk Factor for Lymphoma Swedish study suggests a 21% higher risk for lymphoma in those with tattoos May 28, 2024
Cancer and Intimate-Care Products; Boost for CRC Stool Tests; Biopsy by Ultrasound? News, features, and commentary about cancer-related issues May 17, 2024
CAR-T Plus Stem-Cell Transplant Promising for CD7+ Blood Cancers "All-in-one" approach appears safe, effective, in patients with relapsed/refractory disease Apr 24, 2024
Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests News, features, and commentary about cancer-related issues Apr 19, 2024
Immunotherapy During Pregnancy Just as Safe as Other Cancer Drugs However, use should be avoided "if possible" due to risk of rare immune-related adverse events Apr 17, 2024
Chemo and Heart Disease; Flawed Lung Cancer Screening; New Vax Recommendations News, features, and commentary about cancer-related issues Mar 29, 2024
PD-1 Inhibitor Plus Chemotherapy Shows Promising Activity in Rare Lymphoma The combination induced responses in all 34 patients with advanced extranodal NK/T-cell lymphoma Mar 28, 2024
Broader Cancer Risk With CAR-T? AI for Physician Burnout; 'Lollipops' ID Oral Cancer News, features, and commentary about cancer-related issues Mar 22, 2024
Long-Term Breast Cancer Risk in Hodgkin Lymphoma Survivors Treated With Doxorubicin Dose-dependent increase regardless of age at treatment or chest radiotherapy Mar 19, 2024
EPA Imposes New Limit on Medical Sterilization Chemical, Citing Cancer Risk Rule would lower emission standards for ethylene oxide by 90%, agency says Mar 15, 2024
FDA Approves First CAR-T for Chronic Lymphocytic Leukemia Lisocabtagene maraleucel (Breyanzi) nabs new indication for relapsed or refractory CLL/SLL Mar 15, 2024
Getting Prostate Cancer Drugs Sooner; Limiting Toxic Emissions; FTC Sues 'Charity' News, features, and commentary about cancer-related issues Mar 14, 2024
A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu News, features, and commentary about cancer-related issues Mar 07, 2024
Novel Regimens Yield High Response Rates for Older, Hodgkin Lymphoma Patients Talk of potential cure for some patients with brentuximab plus dacarbazine or nivolumab Mar 06, 2024
